Outcomes of acute Achilles tendon rupture repair with bone marrow aspirate concentrate augmentation
Authors:
- 22 March 2015
- journal article
- Published by Springer Nature in International Orthopaedics
- Vol. 39 (5) , 901-905
Abstract
Optimal treatment of acute Achilles tendon ruptures remains controversial. Positive results using stem-cell-bearing concentrates have been reported with other soft-tissue repairs, but no studies exist on outcomes of bone marrow aspirate concentrate (BMAC) augmentation in primary Achilles tendon repair. We reviewed patients with sport-related Achilles tendon ruptures treated via open repair augmented with BMAC injection from 2009 to 2011. Data on operative complications, strength, range of motion, rerupture, calf circumference and functional improvement through progressive return to sport and the Achilles tendon Total Rupture Score (ATRS) were analysed. A total of 27 patients (28 tendons) treated with open repair and BMAC injection were identified (mean age 38.3 ± 9.6 years). At mean follow-up of 29.7 ± 6.1 months, there were no reruptures. Walking without a boot was at 1.8 ± 0.7 months, participation in light activity was at 3.4 ± 1.8 months and 92 % (25 of 27) of patients returned to their sport at 5.9 ± 1.8 months. Mean ATRS at final follow-up was 91 (range 72–100) points. One case of superficial wound dehiscence healed with local wound care. No soft-tissue masses, bone formation or tumors were observed in the operative extremity. Excellent results, including no re-ruptures and early mobilisation, were observed in this small cohort with open Achilles tendon repair augmented by BMAC. No adverse outcomes of biologic treatment were observed with this protocol. The efficacy of BMAC in the operative repair of acute Achilles tendon ruptures warrants further study. Level of Evidence: IV - TherapeuticKeywords
This publication has 28 references indexed in Scilit:
- Efficacy and complications of open and minimally invasive surgery in acute Achilles tendon rupture: a prospective randomised clinical study—preliminary reportInternational Orthopaedics, 2012
- The Use of Platelet-Rich Plasma in the Management of Foot and Ankle ConditionsOperative Techniques in Sports Medicine, 2011
- Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-upJournal of Shoulder and Elbow Surgery, 2011
- Platelet-Rich Plasma Augmentation for Arthroscopic Rotator Cuff RepairThe American Journal of Sports Medicine, 2010
- Autologous Platelets Have No Effect on the Healing of Human Achilles Tendon RupturesThe American Journal of Sports Medicine, 2010
- Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytesFibrogenesis & Tissue Repair, 2010
- Temporal growth factor release from platelet‐rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expressionJournal of Orthopaedic Research, 2009
- The Achilles Tendon Total Rupture Score (ATRS)The American Journal of Sports Medicine, 2007
- Comparison of Surgically Repaired Achilles Tendon Tears Using Platelet-Rich Fibrin MatricesThe American Journal of Sports Medicine, 2007
- Increasing incidence of Achilles tendon ruptureActa Orthopaedica, 1996